In the News

BioChemics Claims It Can Pay Chunk of $17M SEC Judgment, Law360

September 11, 2018

In a Law360 article, Morgan Lewis partner Sabin Willett discusses private equity firm ADEC’s repealing of the US SEC’s bid to appoint a receiver to oversee the monetization and distribution of the company’s proceedings against Inpellis, a subsidiary of the pharmaceutical company BioChemics. He states in the article that, “if the pools of assets are distinct and don’t require a joint sale, we’re fine. If they do require a joint sale, we’re fine.”

Read the full Law360 article.